Our highlighted selection of Covid-related cross-sectional case control studies from the scientific press for February 2022
BioMed Alliance and 17 other civil society organisations call on policy makers to ensure that the next multiannual EU budget will be fit-for-purpose to address current and future health threats.
Latest Posts
-
-
Our highlighted selection of Covid-related case series and case reports from the scientific press for February 2022. -
Our highlighted selection of Covid-related randomised double-blinded placebo-controlled trials from the scientific press for February 2022 -
Breaking newsCOVID-19COVID-19 Breaking News: Interventional Studies with open label/non-randomised methodology
Our highlighted selection of Covid-related interventional studies with open label or non-randomised methodology from the scientific press for February 2022. -
Our highlighted selection of Covid-related expert opinions from the scientific press for February 2022 -
Our highlighted selection of miscellaneous Covid-related studies from the scientific press for February 2022 -
The first in a brand new series of exclusive video interviews, conducted by the editors of EANpages, asking three questions on one hot topic. -
Our highlighted selection of Covid-related Literature Reviews from the scientific press for February 2022. -
The call is now open for the nomination of candidates for the EAN Board Election 2022. -
EAN NewsFeatured SliderStroke reclassified as neurological disorder in International Classification of Diseases update
The International Classification of Diseases 11 (ICD 11), maintained by the WHO and distributed globally, came into effect on 1 January 2022. The most notable change in the new set of classifications is that stroke has been reclassified as a neurological disorder, having previously been classed as a circulatory system disease for several decades. -
Paper of the MonthCOVID-19Featured SliderCovid-19 Paper of the month: Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis
Our authors of the month conducted a systematic review and meta-analysis in order to summarise the frequency of neurologic manifestations in patients with COVID-19 and to investigate the association of these manifestations with disease severity and mortality. -
Paper of the MonthFeatured SliderResearch Paper of the Month: Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2)
For February we have selected Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomized, placebo-controlled trial. -
Executive PageTop ArticlesFeatured SliderExecutive Page: supporting young neurologists in the European Year of Youth
With 2022 named European Year of Youth by the European Commission, the EAN President Elect takes a look at all the initiatives EAN offers to support young neurologists -
The WHO has made a draft decision to adopt the neurological Global Action Plan at the 75th World Health Assembly in May 2022. -
Our highlighted selection of recent papers from the scientific press for February 2022